EU approves AstraZeneca immunotherapy drug for lung cancer
LONDON (Reuters) – AstraZeneca’s immunotherapy drug Imfinzi has been approved in...
Read MoreSep 24, 2018
LONDON (Reuters) – AstraZeneca’s immunotherapy drug Imfinzi has been approved in...
Read MoreSep 24, 2018
By Gene Emery (Reuters Health) – Doctors in Kentucky reported Monday that two of four paralyzed patients were able to walk again with limited assistance after treatment with electrical stimulation to the portion of the...
Read MoreSep 24, 2018
LONDON (Reuters) – Despite actions taken by companies to prepare for Brexit, there is still a risk of serious supply disruptions for 39 medicines as a result of Britain’s departure from the European Union, the...
Read MoreSep 24, 2018
By Tamara Mathias (Reuters) – The U.S. Food and Drug Administration on Monday approved Boston Scientific Corp’s drug-coated stent Eluvia to treat narrowed arteries in the leg. The medical device maker intends to...
Read MoreSep 24, 2018
By Ben Hirschler LONDON (Reuters) – AstraZeneca’s diabetes drug Farxiga met a key goal...
Read MoreSep 24, 2018
BEIJING (Reuters) – China said on Monday it has confirmed a new outbreak of African swine fever in the Inner Mongolia Autonomous Region of northern China, as authorities struggle to contain the highly contagious disease....
Read MoreSep 24, 2018
By Robin Respaut and Julie Zhu SAN FRANCISCO/HONG KONG (Reuters) – For three whirlwind days...
Read MoreSep 24, 2018
ZURICH (Reuters) – Swiss drugmaker Roche upped its bet on personalized cancer treatment on...
Read MoreSep 24, 2018
MEXICO CITY (Reuters) – More governments should turn away from a repressive war on drugs...
Read MoreSep 21, 2018
By Lisa Rapaport (Reuters Health) – Homeowners in North Carolina and South Carolina who lost...
Read MoreSep 21, 2018
By Lisa Rapaport (Reuters Health) – Prescription drug shortages may drive up prices twice as much as they would rise with medicines in abundant supply, adding $230 million a year to U.S. drug costs, a new study estimates....
Read MoreSep 21, 2018
By Daniel Wiessner (Reuters) – The U.S. Equal Employment Opportunity Commission on Friday...
Read MoreSep 21, 2018
By John Miller ZURICH (Reuters) – Drug giants Novartis, Bayer and Roche on Friday lost a bid to stop British doctors from recommending a cheaper drug option for people with an eye disease that causes blindness, the High...
Read MoreSep 21, 2018
By Lisa Rapaport (Reuters Health) – A new type of “heat-not-burn” cigarette may lead to just as much lung damage as traditional cigarettes, a recent study suggests. So-called “heat-not-burn” devices...
Read MoreSep 21, 2018
By Ankur Banerjee (Reuters Health) – The commonly used painkiller diclofenac may be linked with an increased risk of heart problems, a large Danish study suggests. Diclofenac is a non-steroidal anti-inflammatory drug...
Read MoreSep 21, 2018
SOFIA (Reuters) – An outbreak of a virulent bird flu virus has spread to a farm in southern Bulgaria, the Balkan country’s food safety agency said on Friday. A three-kilometer protection zone was set around the farm...
Read MoreSep 21, 2018
GOMA, Democratic Republic of Congo (Reuters) – Democratic Republic of Congo has confirmed a...
Read MoreSep 21, 2018
By Kate Kelland (Reuters) – More than 3 million people died in 2016 due to drinking too much...
Read MoreSep 21, 2018
(Reuters) – A European Medicines Agency panel on Friday recommended the approval of U.S....
Read MoreSep 21, 2018
(Reuters) – Bayer AG’s long-acting treatment for hemophilia A has won a recommendation from a European Medicines Agency (EMA) panel for the treatment of the rare genetic disorder in which blood does not clot easily....
Read More